8:00am PDT
8:00am PDT
9:00am PDT
11:00am PDT
12:30pm PDT
12:45pm PDT
1:30pm PDT
2:30pm PDT
3:45pm PDT
7:00am PDT
8:00am PDT
10:00am PDT
10:10am PDT
10:15am PDT
11:00am PDT
12:00pm PDT
12:15pm PDT
12:30pm PDT
1:00pm PDT
1:15pm PDT
1:30pm PDT
1:45pm PDT
2:15pm PDT
3:30pm PDT
4:30pm PDT
4:45pm PDT
5:15pm PDT
5:30pm PDT
6:00pm PDT
7:00am PDT
7:30am PDT
8:00am PDT
9:00am PDT
9:15am PDT
9:30am PDT
9:45am PDT
10:00am PDT
10:30am PDT
11:30am PDT
11:40am PDT
11:45am PDT
12:15pm PDT
12:40pm PDT
1:40pm PDT
2:00pm PDT
3:15pm PDT
3:30pm PDT
4:15pm PDT
5:00pm PDT
7:00am PDT
7:30am PDT
8:00am PDT
9:00am PDT
9:15am PDT
9:30am PDT
9:45am PDT
10:00am PDT
10:30am PDT
11:30am PDT
11:40am PDT
12:30pm PDT
12:40pm PDT
12:45pm PDT
1:15pm PDT
1:40pm PDT
2:00pm PDT
3:15pm PDT
3:30pm PDT
4:15pm PDT
#379: From Trials to Real World: How Safety Protocols Impact REMS Room 6C
#381: A New Path Forward for Using Decentralized Clinical Trials Room 10
#380: Incorporating Patient Input into the Design and Conduct of Clinical Trials Room 9
#382: Real World Data Quality for Regulatory Decision-Making Room 1AB
#383: Next-Generation Approaches for Developing Narratives Room 4
#384: Patient Preferences in Decision Making and the PREFER Project: Past, Present, and Future Room 5AB
#385: The Importance of Human Translation for Successful Preclinical Drug Discovery and Cardiac Safety Room 2
#386: Setting the Stage for Effective Stakeholder Collaboration Room 15AB
#387: Global Perspective on ICH E8(R1): General Considerations for Clinical Trials Room 17AB
#388: Convergence of the Regulatory Pathways for Advanced Therapy Medicinal Products Room 6F
#391: Real World Evidence and Artificial Intelligence to Inform Post-Authorization Studies Room 16AB
#392: Breakthrough Therapy and PRIME Expedited Regulatory Pathways: Experience, Analysis, and Reflections from EMA, FDA, and Industry Room 6D
#390: Clinical Trial Innovation: Pathways for Selecting and Developing Novel, Fit-for-Purpose, Technology-Derived Study Endpoints Room 6E
#389: Transparency, Expanded Access Navigator, Right to Try: Helping Patients Get Access to Investigational Medicines? Room 6B
#393: Case Studies in Resolving Quality Issues Room 8
#394: Demystifying Basic Statistical Concepts for Anyone Involved with Clinical Trials Room 11B
#395: Utilization and Evaluation of Innovative Approaches for Efficient Drug Development Room 3
#396: Challenges to Access: Bringing Payers to the Table Room 14B
#397: PowerUp: Stories of Career Transforming Moments Room 14A
4:30pm PDT
8:00am PDT
8:30am PDT
9:00am PDT
10:45am PDT